Form4insider filings, from the source

Company · CIK 0001771910 · SIC 2834 — Pharmaceutical Preparations · NYSE

ADC Therapeutics SA · ADCT

Insider activity reported against this company. All insider holders · On EDGAR ↗

1M3M6M1Y2YAll datashares as filed — not split-adjusted

Reported at this company — common stock

TradeReported (ET)InsiderSharesAvg priceTotalOwned afterΔ stakeFlags
Jun 30, 2026 AForm 4 →Jul 2, 5:17 pm EDTMohamed ZakiChief Medical Officer213,900——896,317—
Jun 30, 2026 AForm 4 →Jul 2, 5:16 pm EDTPeter J GrahamChief Legal Officer221,100——841,640—
Jun 30, 2026 AForm 4 →Jul 2, 5:16 pm EDTJose CarmonaChief Financial Officer203,700——938,076—
Jun 30, 2026 AForm 4 →Jul 2, 5:15 pm EDTAmeet MallikChief Executive Officer, Director675,000——2,121,769—
Jun 1, 2026 AFForm 4 →Jun 3, 5:03 pm EDTRobert AzelbyDirector57,600$3.08$38,808112,805—
Jun 1, 2026 AFForm 4 →Jun 3, 5:03 pm EDTRon SquarerDirector60,196$3.08$46,804123,431—
Jun 1, 2026 AFForm 4 →Jun 3, 5:03 pm EDTVictor SandorDirector57,600$3.08$38,808140,686—
Jun 1, 2026 AFForm 4 →Jun 3, 5:03 pm EDTViviane MongesDirector47,596$3.08$7,996186,447—
Jun 1, 2026 AFForm 4 →Jun 3, 5:02 pm EDTPeter HugDirector47,156$3.08$6,640263,344—
Jun 1, 2026 AFForm 4 →Jun 3, 5:02 pm EDTJean-Pierre BizzariDirector57,600$3.08$38,808139,302—
Jun 1, 2026 AFForm 4 →Jun 3, 5:02 pm EDTTimothy CoughlinDirector57,600$3.08$38,80872,400—

Reported at this company — derivatives (options, RSUs, warrants)

No reported derivative activity in this period.